Propel Bio Management »

Verrica Pharmaceuticals shares owned by Propel Bio Management

Quarter-by-quarter ownership of Verrica Pharmaceuticals (VRCA) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Verrica Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Verrica Pharmaceuticals held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verrica Pharmaceuticals by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $500k 345k 1.45
2024-06-30 $3.1M 425k 7.29

More positions owned by Propel Bio Management

Applied Therapeutics Comm (APLT)
Plains Gp Holdings Lp-cl Comm (PAGP)
Phathom Pharmaceuticals I Comm (PHAT)
Achieve Life Sciences Comm (ACHV)
Tscan Therapeutics Comm (TCRX)
Akero Therapeutics Comm (AKRO)
Madrigal Pharmaceuticals Comm (MDGL)
Avidity Biosciences Comm (RNA)
Ardelyx Comm (ARDX)
Telesat Corp Comm (TSAT)
Abeona Therapeutics Comm (ABEO)
Kymera Therapeutics Comm (KYMR)
Syndax Pharmaceuticals In Comm (SNDX)
Kura Oncology Comm (KURA)
Zevra Therapeutics Comm (ZVRA)

View all positions for Propel Bio Management

Top funds holding Verrica Pharmaceuticals

Armistice Capital
Caligan Partners
Perceptive Advisors
Boothbay Fund Management
Vanguard Group
BlackRock
State Street Corporation
Geode Capital Management
Sovran Advisors
Morgan Stanley
Propel Bio Management
Rhumbline Advisers
Renaissance Technologies
Northern Trust
Simplify Asset Management

View all funds holding Verrica Pharmaceuticals